<DOC>
	<DOCNO>NCT01686568</DOCNO>
	<brief_summary>This study do understand effect dietary omega-3 fat insulin sensitivity adult men woman .</brief_summary>
	<brief_title>Omega-3 Fatty Acids Insulin Sensitivity</brief_title>
	<detailed_description>Dietary omega-3 polyunsaturated fatty acid ( n-3 PUFA ) , include eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) fish oil , prevent insulin resistance rodent , data human ambiguous . No exist study systematically evaluate influence n-3 PUFAs insulin sensitivity beta cell function insulin resistant , non-diabetic human . The Investigators hypothesize 6 month oral supplementation purify EPA/DHA ( 3.9g/day ) significantly improve hepatic peripheral insulin sensitivity beta cell responsiveness insulin-resistant , non-diabetic individual . Based recent work mouse , investigator also hypothesize EPA/DHA increase content function mitochondrion skeletal muscle , measure use combination vivo vitro method . Overall , investigator hypothesize EPA+DHA supplementation improve hepatic peripheral insulin sensitivity insulin resistant human , improvement associate mitochondrial biogenesis attenuate lipid accumulation skeletal muscle liver . A sub-study added participant receive dietary omega-3 fatty acid placebo supplement underwent abdominal subcutaneous adipose tissue biopsy measure content total , pro- ( M1 ) anti- ( M2 ) inflammatory macrophage ( immunohistochemistry ) , crown-like structure ( immunohistochemistry ) , senescent cell ( β-galactosidase staining ) , well two-step euglycemic , pancreatic clamp stable-isotope label precursor ( ( U-13C ) palmitate ) infusion determine insulin concentration need suppress palmitate flux 50 % ( IC50 ( palmitate ) f ) .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<criteria>Inclusion criterion : 1 . Age 1865 year 2 . Insulin resistant ( Homeostasis Model Assessment ( HOMA ) Insulin Resistance ( IR ) ≥2.6 ) Exclusion criterion : 1 . Current use omega3 nutritional supplement 2 . Fasting plasma glucose ≥126 mg/dL 3 . Active coronary artery disease 4 . Participation structure exercise ( &gt; 2 time per week 30 minute longer ) 5 . Smoking 6 . Medications know affect muscle metabolism ( e.g. , beta blocker , corticosteroid , tricyclicantidepressants , benzodiazepine , opiate , barbiturate , anticoagulant ) 7 . Renal failure ( serum creatinine &gt; 1.5mg/dl ) 8 . Chronic active liver disease ( AST &gt; 144 IU/L alanine transaminase ( ALT ) &gt; 165 IU/L ) 9 . Anticoagulant therapy ( warfarin/heparin ) 10. International normalize ratio ( INR ) &gt; 3 11 . Use systemic glucocorticoid 12 . Chronic use NSAIDS aspirin 13 . Pregnancy breastfeed 14 . Alcohol consumption great 2 glasses/day 15 . Hypothyroidism 16 . Fish shellfish allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>